These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Histopathologic evaluation of pretransplantation biopsy as a factor influencing graft function after kidney transplantation in 3-year observation. Sulikowski T; Tejchman K; Ziętek Z; Urasińska E; Domański L; Sieńko J; Romanowski M; Safranow K; Zukowski M; Ciechanowicz A; Ciechanowski K; Ostrowski M Transplant Proc; 2010 Nov; 42(9):3375-81. PubMed ID: 21094782 [TBL] [Abstract][Full Text] [Related]
8. Conversion From Calcineurin to Mammalian Target of Rapamycin Inhibitors in Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials. Glover TE; Watson CJ; Gibbs P; Bradley JA; Ntzani EE; Kosmoliaptsis V Transplantation; 2016 Mar; 100(3):621-9. PubMed ID: 26636736 [TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients. Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428 [TBL] [Abstract][Full Text] [Related]
10. Management of chronic allograft dysfunction by switch over to rapamycin. Sundaram V; Abraham G; Fathima N; Sundaram V; Reddy YN; Mathew M; Sathiah V Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):37-42. PubMed ID: 20061690 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy. Pontrelli P; Rossini M; Infante B; Stallone G; Schena A; Loverre A; Ursi M; Verrienti R; Maiorano A; Zaza G; Ranieri E; Gesualdo L; Ditonno P; Bettocchi C; Schena FP; Grandaliano G Transplantation; 2008 Jan; 85(1):125-34. PubMed ID: 18192922 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation? Zeier M; Van Der Giet M Transpl Int; 2011 Jan; 24(1):30-42. PubMed ID: 20642495 [TBL] [Abstract][Full Text] [Related]
13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
14. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era. Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870 [TBL] [Abstract][Full Text] [Related]
15. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field? Rostaing L; Kamar N J Nephrol; 2010; 23(2):133-42. PubMed ID: 20155724 [TBL] [Abstract][Full Text] [Related]
16. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment. Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973 [TBL] [Abstract][Full Text] [Related]
17. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF; Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978 [TBL] [Abstract][Full Text] [Related]
18. Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi. Becker LE; Weritz B; Yi X; Gross-Weissmann ML; Waldherr R; Zeier M; Sommerer C Transpl Int; 2015 May; 28(5):553-64. PubMed ID: 25630217 [TBL] [Abstract][Full Text] [Related]
20. Systematic Review on Role of Mammalian Target of Rapamycin Inhibitors as an Alternative to Calcineurin Inhibitors in Renal Transplant: Challenges and Window to Excel. Kumar J; Bridson JM; Sharma A; Halawa A Exp Clin Transplant; 2017 Jun; 15(3):241-252. PubMed ID: 27915965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]